Nutex EPS hits $9.38 as Q2 revenue drops 13.6%

For market participants, Nutex's Q2 report is a reminder that headline net income can decouple from revenue reality: a $83.5M year-over-year swing to $65.8M profit came almost entirely from cost-side adjustments, not top-line growth. With hospital revenue down 12.1% on a same-facility basis, investors must distinguish accounting-driven margin expansion from sustainable operating leverage.

Nutex Health's second-quarter report delivered a sharp contrast between top-line contraction and bottom-line explosion. Total revenue fell 13.6% year over year to $210.8 million, reflecting tougher comparisons from early success in the independent dispute resolution process in the prior-year period. Yet net income swung to $65.8 million, or $9.38 per diluted share, from a net loss of $17.7 million, or -$2.95 per share, a year earlier. Adjusted EBITDA climbed 25.7% to $90.0 million, and gross margin expanded to 67% from 51.2%. The profit surge was primarily cost-side: a retroactive HaloMD amendment reduced contract services expense by $38.4 million in the quarter, and the CMS administrative fee reduction from $115 to $15 per party effective June 11, 2026 contributed another $4.3 million. Stock-based compensation fell to $2.9 million, further flattering the earnings line.

“

Crucial, Omada raised full-year revenue guidance to $334-$340 million and adjusted EBITDA guidance to $21-$27 million, a fourfold EBITDA increase versus 2025, with $222 million in cash and no debt.

Beneath the profit bridge, Nutex's revenue engine softened. Hospital division revenue declined 14.6% to $201.9 million, with same-hospital revenue down 12.1%. Total patient visits grew 9.6% to 49,962, and same-hospital visits rose 6.3%, so the problem is not demand but realization: the prior-year period benefited from favorable IDR outcomes that did not repeat. Population health revenue rose 16% to $8.9 million, but remains a small share of the total. The result is a margin story with a top-line reality check. Management's operational efficiencies and reduced arbitration-related expenses are real, but investors must assess whether the pay-on-collected HaloMD structure, retroactive to May 2024, creates a one-time reset or durable cost relief.

The broader Q2 2026 earnings cluster shows adjacent digital-health and software businesses generating organic revenue growth alongside margin gains. Omada Health grew revenue 43% to $88 million, driven by its GLP-1 Care Track and increasing multicondition penetration across its cardiometabolic suite. Gross margin expanded 700 basis points to 73%, adjusted EBITDA reached a record $11 million, and total members grew 45% to 1.1 million. Crucial, Omada raised full-year revenue guidance to $334-$340 million and adjusted EBITDA guidance to $21-$27 million, a fourfold EBITDA increase versus 2025, with $222 million in cash and no debt. This is a recurring-revenue digital-care model with strengthening unit economics: trailing 12-month revenue per member rose to $284 from $279, cost to serve declined more than 10%, and incremental adjusted EBITDA margin hit 41%.

Software-oriented names in the cluster reinforce the AI and recurring-revenue theme. Alarm.com reported SaaS and license revenue of $188.8 million, up 11.1% and $3.2 million above guidance midpoint, with total revenue of $277.7 million and 95% revenue retention for the third consecutive quarter. Growth initiatives—EnergyHub, commercial, and international—reached 35% of revenue and grew over 30%, while international subscriber accounts hit 1 million. Grindr grew revenue 33% to $138.1 million, with app-based revenue up 30% and advertising up 44%, and raised full-year revenue guidance to approximately $540 million. Grindr's AI-native software processes increased engineering productivity 2.5-fold and generated an estimated $60 million in annual cost avoidance. Arteris, a semiconductor IP connectivity vendor, grew revenue 46% to $24.1 million, with ACV plus royalties reaching a record $99.5 million and remaining performance obligation up 36% to $135 million, with AI infrastructure driving the largest enterprise deals.